Locations:
Search IconSearch
March 2, 2022/Neurosciences/Podcast

Neurostimulation for Treatment of Obstructive Sleep Apnea (Podcast)

An in-depth look at this alternative for patients who cannot tolerate PAP therapy

While there are comprehensive treatment options for obstructive sleep apnea (OSA), the disorder is underrecognized and underdiagnosed, says Jessica Vensel Rundo, MD, MS, Director of the Sleep Neuromodulation Program in Cleveland Clinic’s Sleep Disorders Center.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“About 25% to 50% of males and 10% to 25% of females have some degree of obstructive sleep apnea,” says Dr. Vensel Rundo. “That translates to many millions of Americans.”

In 2014, a new category of surgical therapy became available to help this population when the FDA approved the first neurostimulation device to treat OSA. In the latest episode of Cleveland Clinic’s Neuro Pathways podcast, Dr. Vensel Rundo discusses OSA and hypoglossal nerve stimulation, providing insight on the following:

  • Positive airway pressure (PAP) therapy as the first line of treatment for OSA
  • Screening criteria and ideal candidates for airway neurostimulation
  • Implantation and function of the transcutaneous electrical stimulator
  • Patient outcomes following neurostimulation
  • Potential future devices, including a bilateral hypoglossal nerve stimulator and a continuous negative expiratory pressure device

Click the podcast player above to listen to the episode now, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

This activity has been approved for AMA PRA Category 1 Credit™. After listening to the podcast, you can claim your credit here.

Excerpt from the episode

Podcast host Glen Stevens, DO, PhD: Would you recommend that anybody who is thinking about airway neurostimulation see a sleep specialist, or can they go to their general neurologist for this?

Dr. Vensel Rundo: I think it usually is most helpful if they can be referred to a sleep specialist, just to discuss in more detail what their issues are with PAP therapy and what other potential options there might be in addition to hypoglossal nerve stimulation.

Advertisement

Also, we see a number of patients who are intolerant to PAP therapy or just struggle with whatever their treatment option is for sleep apnea. Other patients may also struggle because they have additional sleep disorders like insomnia, restless legs syndrome or circadian rhythm disorders. In these cases, a sleep specialist is best equipped to assess why these patients may have difficulties adhering to their current treatment option and to determine whether other sleep disorders may be contributing to these difficulties.

Advertisement

Related Articles

William Clifton, MD, against a decorative background
November 4, 2024/Neurosciences/Podcast
Adult Idiopathic Scoliosis: Essentials of Diagnosis and Treatment (Podcast)

Early intervention yields the best outcomes, but surgery can benefit older patients as well

Creative illustration of a brain
October 16, 2024/Neurosciences/Podcast
Diagnosing Atypical Parkinsonian Disorders (Podcast)

Patient history plays a key role in identifying the condition

dr. daniel ontaneda against a decorative background
October 2, 2024/Neurosciences/Podcast
Takeaways From the New Diagnostic Criteria for Multiple Sclerosis (Podcast)

A co-author explains some of the key McDonald criteria revisions

Dr. Imad Najm against a decorative background
September 16, 2024/Neurosciences/Podcast
Temporal Lobe Epilepsy and the Potential of Gene Therapy (Podcast)

Investigational gene approaches offer hope for a therapeutically challenging condition

alison stout, DO, against a decorative backdrop
August 9, 2024/Neurosciences/Podcast
Evaluation and Interventional Treatment of Axial Lumbar Back Pain (Podcast)

This common condition remains tough to work up and diagnose, and treatment options are limited

Dr. Amy Kunchok against decorative background
July 16, 2024/Neurosciences/Podcast
What to Know About Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) (Podcast)

It’s time to get familiar with this emerging demyelinating disorder

receptor activity for myasthenia gravis medications
July 3, 2024/Neurosciences/Podcast
Myasthenia Gravis: Unmet Needs and Efforts to Address Them (Podcast)

An overview of associated antibodies, therapies for antibody-positive disease and the outlook for atypical forms of MG

adult female figure suffering headache
June 17, 2024/Neurosciences/Podcast
Migraine Relief: Providing Preventive and Abortive Therapies (Podcast)

A close look at the growing array of options for episodic and chronic migraine

Ad